Nuvalent Analyst Ratings
BenzingaApr 17 19:53
Nuvalent Analyst Ratings
BenzingaApr 1 22:56
Leerink Partners Upgrades Nuvalent to Outperform From Market Perform, Raises Price Target to $110 From $69
MT NewswiresApr 1 20:19
Nuvalent Analyst Ratings
BenzingaMar 6 23:57
JP Morgan Maintains Overweight on Nuvalent, Raises Price Target to $98
BenzingaMar 6 23:58
Guggenheim Assumes Nuvalent at Buy, Announces Price Target of $99
BenzingaFeb 29 03:44
BMO Capital Maintains Outperform on Nuvalent, Raises Price Target to $102
BenzingaFeb 28 22:19
Nuvalent Analyst Ratings
BenzingaFeb 28 22:17
Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL) and Arcutis Biotherapeutics (ARQT)
TipRanksFeb 28 05:40
Analysts' Top Healthcare Picks: Privia Health Group (PRVA), Nuvalent (NUVL)
TipRanksFeb 28 02:40
Baird Initiates Coverage On Nuvalent With Outperform Rating, Announces Price Target of $105
BenzingaFeb 23 18:50
Nuvalent Analyst Ratings
BenzingaFeb 23 18:48
Wedbush Raises Nuvalent's Price Target to $99 From $82, Maintains Outperform Rating
MT NewswiresFeb 12 21:58
Analysts Have Conflicting Sentiments on These Healthcare Companies: Nuvalent (NUVL), NewAmsterdam Pharma Company (NAMS) and Marinus (MRNS)
TipRanksJan 9 14:40
Hold Rating on Nuvalent Continues: Evaluating the Potential of NVL-655 and Anticipated Market Shifts
TipRanksNov 16, 2023 20:17
TD Cowen Keeps Their Buy Rating on Nuvalent (NUVL)
TipRanksNov 15, 2023 01:16
Piper Sandler Remains a Buy on Nuvalent (NUVL)
TipRanksOct 20, 2023 19:19
BMO Capital Maintains Outperform on Nuvalent, Raises Price Target to $79
BenzingaOct 19, 2023 23:49
Nuvalent Analyst Ratings
BenzingaOct 19, 2023 23:47
Nuvalent (NUVL) Gets a Buy From Stifel Nicolaus
TipRanksOct 19, 2023 10:05
No Data
No Data